Immutep - ADR Peer Comparison

$4.68

$-0.21 (-4.20%)

As on 29-Sep-2026 11:33EDT

Market cap

$39 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Immutep - ADR	Alterity Therapeutics - ADR
Market cap ($ Mln)	39	67
Revenue (A$ Mln)	14	--
Net Profit (A$ Mln)	-77.57	-22.89
Net Margin (%)	-1,030.32	-531.34
RoE (%)	-75.62	-53.78
Price to Earnings	--	--
Price-To-Book	0.89	2.27

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (A$ Mln)

	Immutep - ADR	Alterity Therapeutics - ADR
Operating Revenue	14.24	0.00
Cost of Revenue	2.42	0.11
Gross Profit	11.82	-0.11
Operating Expenses	93.87	27.69
Operating Profit (EBIT)	-82.05	-27.80
Other Income	--	--
Profit before Tax	-77.57	-26.31
Provision for Tax	--	-3.42
Profit after Tax (Net Income)	-77.57	-22.89
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities (A$ Mln)

	Immutep - ADR	Alterity Therapeutics - ADR
Shareholder's Funds	61.54	42.73
Minority Interest	--	--
Non-Current Liabilities	7.57	0.14
Current Liabilities	14.16	3.16
Total Liabilities	83.27	46.02

Assets (A$ Mln)

	Immutep - ADR	Alterity Therapeutics - ADR
Non-Current Assets	2.64	0.19
Current Assets	80.63	45.83
Total Assets	83.27	46.02
Total Debt*	1.05	0.19
Net Current Assets	66.47	42.67

Cashflow (A$ Mln)

	Immutep - ADR	Alterity Therapeutics - ADR
Cash From Operating Activities	-54.25	-22.03
Cash Flow from Investing Activities	55.23	7.34
Cash from Financing Activities	-0.21	18.71
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Immutep - ADR	Alterity Therapeutics - ADR
ROCE (%)	-74.64	-53.56
ROE (%)	-75.62	-53.78
ROA (%)	-64.57	-49.73
EBIT Margin (%)	--	--
Net Margin (%)	-544.79	--
Cash Profit Margin (%)	--	--

Growth Ratios

	Immutep - ADR	Alterity Therapeutics - ADR
Revenue Growth (%)	1.82	-1.00
EBIT Growth (%)	--	--
Net Profit Growth (%)	-26.27	-88.43
EPS Growth (%)	-0.25	-0.30
Book Value Growth (%)	--	--

Valuation Ratios

	Immutep - ADR	Alterity Therapeutics - ADR
Price / Earnings	-0.79	-4.25
Price / Book Value	1.00	2.28
Dividend Yield (%)	--	--
EV/EBITDA	0.15	-2.17
Market Cap ($ Cr)	--	--

Solvency Ratios

	Immutep - ADR	Alterity Therapeutics - ADR
Debt to Equity	0.02	0.00
Short term debt to equity ratio	0.00	0.00
Current Ratio	5.69	14.52
Quick Ratio	--	--
Interest Coverage	-1,235.43	--

Operating Efficiency Ratios

	Immutep - ADR	Alterity Therapeutics - ADR
Debtors to sales (%)	67.59	--
Asset Turnover	0.12	0.00
Receivable days	123.53	--
Inventory Days	--	--
Payable days	862.20	2,678.46
Cash Conversion Cycle	--	--

Annual
Quarterly